Geschatte realtime
Cboe BZX
17:29:31 02-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
7,525
USD
|
+2,94%
|
|
+20,10%
|
-14,48%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
824,9
|
976,3
|
670,5
|
315,5
|
1.020
|
1.079
|
-
|
-
|
Bedrijfswaarde
1 |
824,9
|
976,3
|
670,5
|
315,5
|
1.020
|
1.079
|
1.079
|
1.079
|
K/w-verhouding
|
-31,6
x
|
-11,8
x
|
-40,3
x
|
-8,42
x
|
23,7
x
|
24
x
|
19,7
x
|
15,1
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
-
|
3,93
x
|
2,59
x
|
1,18
x
|
3,17
x
|
2,98
x
|
2,66
x
|
2,26
x
|
Bedrijfswaarde/omzet
|
-
|
3,93
x
|
2,59
x
|
1,18
x
|
3,17
x
|
2,98
x
|
2,66
x
|
2,26
x
|
Bedrijfswaarde/EBITDA
|
-
|
-
|
-
|
80,6
x
|
17,4
x
|
13,5
x
|
12
x
|
10
x
|
Bedrijfswaarde/FCF
|
-
|
-
|
-
|
-
|
41,2
x
|
18
x
|
12,2
x
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
2,43%
|
5,54%
|
8,2%
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
108.828
|
107.521
|
111.010
|
113.500
|
116.358
|
147.604
|
-
|
-
|
Referentieprijs
2 |
7,580
|
9,080
|
6,040
|
2,780
|
8,770
|
7,310
|
7,310
|
7,310
|
Datum van publicatie
|
6/07/20
|
8/03/21
|
28/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
-
|
248,2
|
258,6
|
267,8
|
321,5
|
361,5
|
406,2
|
477,9
|
EBITDA
1 |
-
|
-
|
-
|
3,914
|
58,48
|
79,63
|
89,77
|
107,6
|
Bedrijfsresultaat (EBIT)
1 |
-
|
-45,4
|
-5,035
|
-24,97
|
55,06
|
58,5
|
68,39
|
87,62
|
Operationele Marge
|
-
|
-18,29%
|
-1,95%
|
-9,32%
|
17,13%
|
16,18%
|
16,84%
|
18,33%
|
Resultaat voor belastingen (EBT)
1 |
-
|
-61,54
|
-10,04
|
-29,99
|
30,63
|
57,36
|
77,2
|
127
|
Nettowinst (verlies)
1 |
-25,58
|
-83,33
|
-16,42
|
-36,78
|
55,8
|
45,27
|
55,8
|
72,99
|
Nettomarge
|
-
|
-33,57%
|
-6,35%
|
-13,73%
|
17,36%
|
12,52%
|
13,74%
|
15,27%
|
WPA
2 |
-0,2400
|
-0,7700
|
-0,1500
|
-0,3300
|
0,3700
|
0,3040
|
0,3720
|
0,4850
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
24,79
|
59,8
|
88,5
|
-
|
FCF-marge
|
-
|
-
|
-
|
-
|
7,71%
|
16,54%
|
21,79%
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
42,39%
|
75,09%
|
98,59%
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
44,43%
|
132,1%
|
158,62%
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
6/07/20
|
8/03/21
|
28/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
67,41
|
58,89
|
66,88
|
67,69
|
74,38
|
71,68
|
81,26
|
81,71
|
86,83
|
84,71
|
89,36
|
91,91
|
95,52
|
90,9
|
98,7
|
EBITDA
1 |
-
|
-
|
-
|
-0,724
|
7,317
|
5,543
|
14,1
|
17,62
|
21,22
|
18,66
|
19,77
|
19,58
|
20,93
|
18,2
|
23,4
|
Bedrijfsresultaat (EBIT)
1 |
3,301
|
-9,3
|
-9,636
|
-7,103
|
1,072
|
-3,381
|
2,788
|
10,82
|
20,41
|
13,2
|
14,35
|
14,98
|
15,95
|
12,8
|
18
|
Operationele Marge
|
4,9%
|
-15,79%
|
-14,41%
|
-10,49%
|
1,44%
|
-4,72%
|
3,43%
|
13,24%
|
23,51%
|
15,58%
|
16,06%
|
16,3%
|
16,7%
|
14,08%
|
18,24%
|
Resultaat voor belastingen (EBT)
1 |
2,107
|
-10,43
|
-10,81
|
-8,373
|
-0,381
|
-4,932
|
1,126
|
9,125
|
13,91
|
11,41
|
14,25
|
15,24
|
16,51
|
12,8
|
18
|
Nettowinst (verlies)
1 |
0,618
|
-12,08
|
-12,5
|
-10,1
|
-2,11
|
-6,667
|
-0,528
|
6,761
|
44,83
|
9,261
|
11,33
|
11,96
|
12,85
|
9,6
|
13,5
|
Nettomarge
|
0,92%
|
-20,5%
|
-18,68%
|
-14,92%
|
-2,84%
|
-9,3%
|
-0,65%
|
8,27%
|
51,63%
|
10,93%
|
12,68%
|
13,02%
|
13,46%
|
10,56%
|
13,68%
|
WPA
2 |
0,0100
|
-0,1100
|
-0,1100
|
-0,0900
|
-0,0200
|
-0,0600
|
-
|
0,0600
|
0,3200
|
0,0600
|
0,0760
|
0,0820
|
0,0840
|
0,0600
|
0,0900
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
28/02/22
|
3/05/22
|
2/08/22
|
2/11/22
|
28/02/23
|
2/05/23
|
1/08/23
|
30/10/23
|
28/02/24
|
30/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
24,8
|
59,8
|
88,5
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
-
|
1,51
|
1,99
|
4,6
|
5
|
-
|
Capex/omzet
|
-
|
-
|
-
|
0,57%
|
0,62%
|
1,27%
|
1,23%
|
-
|
Datum van publicatie
|
6/07/20
|
8/03/21
|
28/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Laatste slotkoers
7,31
USD Gemiddelde koersdoel
12,52
USD Spread / Gemiddelde doel +71,23% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -14,48% | 1,08 mld. | | -19,12% | 129 mln. | | -9,54% | 66,2 mln. | | +6,78% | 60,77 mln. | | -0,60% | 51,93 mln. |
Bio Medische Hulpmiddelen
|